Should the dose of antituberculosis drugs be reduced in patients with liver disease?
Pillans, P.I.
South African Medical Journal 67(14): 527
1985
ISSN/ISBN: 0256-9574 PMID: 3992375 Document Number: 244443
Document emailed within 1 workday
Related Documents
Sukhanov, D.S.; Vinogradova, T.I.; Zabolotnykh, N.V.; Vitovskaia, M.L.; Kovalenko, A.L. 2014: The hepatotropic activity of runihol and ademethionine against experimental liver damage caused by first-line antituberculosis drugs Arkhiv Patologii 76(2): 26-30Pacetti, U.; Veltri, E.; Fattoruso, S.Ileana.Sara.; Cardillo, F.D'Assisi.; Evangelista, S.; Cognetti, F.; Fabi, A. 2013: Single-dose palonosetron and dose-reduced regimen of dexamethasone in preventing nausea and vomiting by anthracycline-including chemotherapy in patients with early breast cancer Anticancer Research 33(4): 1721-1724
Arase, Y. 2015: Prolonged maintenance therapy by low dose interferon for HCV patients with chronic liver disease Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 284-289
Lejeune, P.; Desager, J.P.; Meunier, H.; Harvengt, C. 1988: Kinetics of a single dose combination of nifedipine/acebutolol in patients with chronic liver disease International Journal of Clinical Pharmacology Therapy and Toxicology 26(10): 513-516
Canetti, G.; Kaczmierzak, A.; Le Lirzin, M. 1971: The classification of antituberculosis drugs according to their blood levels in man Revue de Tuberculose et de Pneumologie 35(1): 5-38
Kawahara, S.; Tada, A.; Nagare, H. 1999: Clinical evaluation of new quinolones as antituberculosis drugs Kekkaku: 74(1): 71-75
Fang, B.-z.; Liu, Z.-z.; He, G.-s.; Miao, M.; Wang, X.-L.; Qiu, H.-y.; Jin, Z.-m.; Tang, X.-w.; Han, Y.; Fu, Z.-z.; Ma, X.; Sun, A.-n.; Wu, D.-p.; Ruan, C.-g. 2013: Lower risk myelodysplastic syndrome patients with transfusion dependent treated by dose-reduced decitabine Zhonghua Yi Xue Za Zhi 93(40): 3189-3192
Müting, D.; Dohn, P.; Reikowski, J. 1972: Effect of high-dose, intravenous and oral administration of essential phospholipids on protein and lipid metabolism as well as enzyme activities in patients with chronic liver disease Verhandlungen der Deutschen Gesellschaft für Innere Medizin 78: 1389-1392
Mule, A.; Sirohi, P.; Ram, N. 2018: Prevalence of Chronic Liver Disease Among the Patients of Celiac Disease and Effect of Gluten-Free Diet on Outcome of Liver Disease: a Prospective Study Journal of the Association of Physicians of India 66(3): 34-36
Winkler, M.; Ringe, B.; Jost, U.; Gubernatis, G.; Pichlmayr, R. 1993: Plasma level-guided low-dose FK 506 therapy in patients with early liver dysfunction after liver transplantation Transplantation Proceedings 25(4): 2688-2690
Zorić, M.; Jarebica, M.; Teofanović, D.; Toula, Z.; Milicević, N. 1977: Evaluation of the effectiveness of different combinations of antituberculosis drugs in the treatment of pulmonary TB (author's transl Plucne Bolesti i Tuberkuloza 29(3-4): 207-217
Djiba, M.L.; Sow, A.I.; Ndiaye, M.; Dromigny, J.A. 2004: Evaluation of E-test method in determination of susceptibility of Mycobacterium tuberculosis to four antituberculosis drugs Dakar Medical 49(3): 185-191
Mendoza, R.; De Donato, M.; de Waard, J.H.; Takiff, H.; Bello, T.; Chirinos, G. 2010: Susceptibility of M. tuberculosis to antituberculosis drugs as determined by two methods, in Sucre state, Venezuela Investigacion Clinica 51(4): 445-455
McGettigan, P.; Roderick, P.; Mahajan, R.; Kadam, A.; Pollock, A.M. 2015: Use of Fixed Dose Combination (FDC) Drugs in India: Central Regulatory Approval and Sales of FDCs Containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Metformin, or Psychotropic Drugs PLOS Medicine 12(5): E1001826; Discussion E1001826
Virukalpattigopalratnam, M.P.; Singh, T.; Ravishankar, A.C. 2013: Heptral (ademetionine) in patients with intrahepatic cholestasis in chronic liver disease due to non-alcoholic liver disease: results of a multicentre observational study in India Journal of the Indian Medical Association 111(12): 856-859
Kuze, F.; Sakurai, N.; Ogino, F.; Togawa, S. 1986: Combined versus single-drug studies on susceptibilities of Mycobacterium avium-intracellulare to antituberculosis drugs on Ogawa medium Kekkaku: 61(6): 341-349
Bhatt, A.D.; Bhatt, N.S. 1996: Indigenous drugs and liver disease Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 15(2): 63-67
Aletaha, D.; Smolen, J.S. 2002: Effectiveness profiles and dose dependent retention of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. An observational study Journal of Rheumatology 29(8): 1631-1638
Schutz, C.; Ismail, Z.; Proxenos, C.J.; Marais, S.; Burton, R.; Kenyon, C.; Maartens, G.; Wilkinson, R.J.; Meintjes, G. 2012: Burden of antituberculosis and antiretroviral drug-induced liver injury at a secondary hospital in South Africa South African Medical Journal 102(6): 506-511
Costin, M.; Tesloianu, A.; Mihăescu, T.; Butnaru, E. 2012: Therapeutic approach in a case of allergic reaction to antituberculosis drugs -- a case report Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 116(2): 487-489